China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A RealWorld Study of Aparloplimab Toripalimab for FirstLine Treatment of Advanced Gastrointestinal Tumors'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136148
Registration Time: 2026/11/06
Type: Observational study
Primary Sponsor: HenanCancerHospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347471
Published by HT Digital Content Services with permission from Health Daily Digest....